appliedclinicaltrialsonline13h
HELIOS-B Trial Confirms Amvuttra Reduces Mortality, Cardiovascular Events in ATTR-CM Patients
Phase III HELIOS-B trial found that Amvuttra (vutrisiran) also preserved functional capacity and quality of life in patients ...
appliedclinicaltrialsonline14h
Reaching Diverse Patient Populations With Personalized Treatment Methods
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical ...
appliedclinicaltrialsonline17h
2025 Trends: Streamlining Data at the Site Level
In this video interview, Kimberly Tableman, founder & CEO, ESPERO, discusses how EDC and EHR data can be streamlined to ...
appliedclinicaltrialsonline3d
Meg Rivers
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
Hilde Vanaken, Rebecca Zeising, Bethany Pryski, Liz Goodman
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
Somaraju Lokaranjan
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
Yaning Wang, PhD
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
Julie Schulman
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
Carl Anderson
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
appliedclinicaltrialsonline3d
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a ...
appliedclinicaltrialsonline3d
2025 Trends: Leveraging Data Standards
In this video interview, Kimberly Tableman, founder & CEO, ESPERO, highlights how data standards are empowering the use of ...